Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis

11Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic sclerosis is a rare chronic autoimmune disease, which mainly manifests as immune disorders, vascular damage, and progressive fibrosis. The etiology of SSc is complex and involves multiple factors. Both genetic and environmental factors are involved in its pathogenesis. As one of the molecular mechanisms of environmental factors, epigenetic regulation plays an important role in the occurrence and development of systemic sclerosis, which involves DNA methylation, histone modification and non-coding RNA regulation. This review summarizes research advances in epigenetics, including exosomes, lncRNA, and mentions possible biomarkers and therapeutic targets among them.

Cite

CITATION STYLE

APA

Yu, J., Tang, R., & Ding, K. (2022). Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis. International Journal of General Medicine. Dove Medical Press Ltd. https://doi.org/10.2147/IJGM.S356877

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free